GTBP
Gt Biopharma
$0.33
+$0.01 (+3.09%)Jul 27, 2026
Key metrics
The numbers that frame GTBP today
- Market cap
- $12.05M
- P/E (TTM)
- -0.3
- EV / FCF
- -0.2
- ROIC
- 7,096.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.26
- 52wk High
- $2.22
Growth
Revenue and earnings trend for GTBP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about GTBP
Is Gt Biopharma a good buy?
No. Gt Biopharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Gt Biopharma is selling at a very high price.
What is the market capitalization of GTBP?
Gt Biopharma's market capitalization is $12.05M.
What is the P/E ratio for GTBP stock?
Gt Biopharma's current P/E ratio is -0.3.
What is the 52-week high for GTBP stock?
The 52-week high for Gt Biopharma is $2.22. The current close of $0.33 is 85% below that high.
What is the 52-week low for GTBP stock?
The 52-week low for Gt Biopharma is $0.26. The current close of $0.33 is 28% above that low.
Does GTBP stock pay dividends?
Gt Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for GTBP?
Gt Biopharma's Debt / Equity ratio is 0.